Microbot Medical Inc.
MBOT
$2.41
$0.114.78%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.46M | 2.69M | 1.61M | 1.56M | 1.67M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.14M | 3.86M | 3.72M | 3.02M | 3.43M |
| Operating Income | -4.14M | -3.86M | -3.72M | -3.02M | -3.43M |
| Income Before Tax | -3.46M | -3.58M | -3.50M | -2.60M | -3.39M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.46M | -3.58M | -3.50M | -2.60M | -3.39M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.46M | -3.58M | -3.50M | -2.60M | -3.39M |
| EBIT | -4.14M | -3.86M | -3.72M | -3.02M | -3.43M |
| EBITDA | -4.13M | -3.85M | -3.71M | -3.01M | -3.40M |
| EPS Basic | -0.05 | -0.07 | -0.10 | -0.08 | -0.20 |
| Normalized Basic EPS | -0.03 | -0.05 | -0.06 | -0.06 | -0.12 |
| EPS Diluted | -0.05 | -0.07 | -0.10 | -0.08 | -0.20 |
| Normalized Diluted EPS | -0.03 | -0.05 | -0.06 | -0.06 | -0.12 |
| Average Basic Shares Outstanding | 67.31M | 48.10M | 36.49M | 31.09M | 17.19M |
| Average Diluted Shares Outstanding | 67.31M | 48.10M | 36.49M | 31.09M | 17.19M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |